英文名称
4,4,4-Trifluoro-1-(4-fluorophenyl)butane-1,3-dione
4,4,4-三氟-1-(4-氟苯基)丁烷-1,3-二酮
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
4,4,4-Trifluoro-1-(4-fluorophenyl)butane-1,3-dioneis an intermediate in the synthesis of Mavacoxib (M197900) which is a long-acting COX-2 Inhibitor and is developed as a veterinary drug used to treat pain and inflammation with degenerative joint disease for dogs.